Helping more people get the treatments they
need today—while we work on what’s next.

Our medicines include therapies for cancer, autoimmune and inflammatory conditions, eye disease, and more.

FDA-approved medicines

Biosimilars

Product
Websites
Prescribing Information

INFLECTRA®*

(infliximab-dyyb)

For patients For healthcare providers Prescribing Information, including Boxed Warning

TRUXIMA®**

(rituximab-abbs)

For patients For healthcare providers Prescribing Information, including Boxed Warning

HERZUMA®**

(trastuzumab-pkrb)

For patients For healthcare providers Prescribing Information, including Boxed Warning

VEGZELMA®

(bevacizumab-adcd)

For patients For healthcare providers Prescribing Information

Adalimumab-aaty

For patients For healthcare providers Prescribing Information, including Boxed Warning

STEQEYMA®

(ustekinumab-stba)

For patients For healthcare providers Prescribing Information

OSENVELT®

(denosumab-bmwo)

For patients For healthcare providers Prescribing Information

STOBOCLO®

(denosumab-bmwo)

For patients For healthcare providers Prescribing Information, including Boxed Warning and REMS

AVTOZMA®

(tocilizumab-anoh)

For patients For healthcare providers Prescribing Information, including Boxed Warning

OMLYCLO®

(omalizumab-igec)

For patients For healthcare providers Prescribing Information, including Boxed Warning

Novel biologics

Product
Websites
Prescribing Information

ZYMFENTRA®

(infliximab-dyyb)

For patients For healthcare providers Prescribing Information, including Boxed Warning

Treatments for today while building for tomorrow.

See our pipeline

*Manufactured by Celltrion, commercialized by Pfizer

**Manufactured by Celltrion, commercialized by Teva